Actinogen Medical Limited (ACW) - Research

$0.014

ACW General Information +

ASX Code ACW
Website http://www.actinogen.com.au
GICS Sub-Industry Biotechnology
Market Cap ($M) 15
Current Price $0.014
Day High $0.014
Day Low $0.014
Last Close $0.014
Price Movement - ( No change )
Prices as at 16:40, 22 May 2019
+Security prices are delayed by at least 20 minutes and are indicative only.

ACW Company Overview

Business Description

Actinogen Medical Limited (ACW, formerly Actinogen Limited) is focused on the treatment of Alzheimer's Disease and mild cognitive impairment, a transitional stage of cognitive impairment between normal aging and the more serious conditions of Alzheimer's and dementia. It is developing a novel drug to treat the condition and other age-related neurodegenerative diseases. Xanamem is a lead product of Actinogen for the treatment of Alzheimer.

ACW Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2018 A -6.23 -0.90 0.00% 0.00 0.00 0.00% 0.0%
2017 A -3.19 -0.50 0.00% 0.00 0.00 0.00% 0.0%
2016 A -3.63 -0.60 0.00% 0.00 0.00 0.00% 0.0%

ACW Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2016 A 2017 A 2018 A 2016 A 2017 A 2018 A 2016 A 2017 A 2018 A
Actinogen Medical (ACW) $16M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
CSL (CSL) $93,449M 0.3775 0.1375 0.1291 39.2913 34.5414 30.5917 1.50% 1.32% 1.52%
Clinuvel Pharmaceuticals (CUV) $1,410M 0.8671 0.0000 0.0000 107.8652 0.0000 0.0000 0.07% 0.00% 0.00%
Mesoblast (MSB) $735M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

ACW Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 0.76 0.00
Market 0.68 14.30 1.18 1.03
Sector 1.04 26.00 3.30 2.13

ACW Directors

Name Position Start Date
Dr John (Bill) William Ketelbey Chief Executive Officer, Managing Director 18 Dec 2014
Dr Geoffrey E.D Brooke Non-Executive Chairman, Non-Executive Director 1 Mar 2017
Dr George Morstyn Non-Executive Director 1 Dec 2017
Mr Malcolm John McComas Non-Executive Director 4 Apr 2019

ACW Management

Name Position
Peter Webse Company Secretary

ACW Substantial Shareholders

Holding Name
187,122,994 (19.90%) BVF Partners L.P

ACW Calendar of Events

Date Event
21 February 2020 Report (Interim)
22 October 2019 Report (Annual)
28 August 2019 Report (Prelim)
28 August 2019 Report (Annual)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.